Renal Denervation in the Real World – Practical Guidance for New Users: On-demand
Published: 25 April 2022
In this chapterised, on-demand version of the live broadcast, Radcliffe Medical Education brings together a globally-renowned European and American faculty to share best practices on resistant hypertension and renal denervation (RDN).
This programme has been carefully curated for healthcare professionals that manage patients with resistant hypertension. This expert guidance will distil the most important practical points on identifying candidates for RDN. The programme aims to draw attention to the current scale of resistant hypertension in the hypertensive population and impart understanding on appropriate patient selection for RDN.
Prof Roland Schmieder (University Hospital Erlangen, DE) moderates proceedings, and is joined by Prof Michel Burnier (University Hospital of Lausanne, CH), Prof Cara East (Texas A&M College of Medicine, US) and Prof Konstantinos Tsioufis (University of Athens, GR) for a series of insightful presentations and discussions.
- Assess the current global burden of resistant hypertension
- Carry out appropriate assessments to identify resistant hypertension
- Identify patients most likely to benefit from RDN
- Recall the practical considerations for adopting RDN into routine practice
- Recall the latest data on RDN from recent clinical trials
- Specialists engaged in treating hypertension
- General Practitioners
- General Cardiologists
More from this programme
Introduction and What Is the Place of RDN Today?
Practice-based Principles For the Future Use of Renal Denervation
What Can Be Expected on RDN in the Future?
Professor of Medicine and Head of the Division of Nephrology and Hypertension Consultation
Michel Burnier is a Professor of Medicine and Head of the Division of Nephrology and Hypertension Consultation at the University Hospital of Lausanne in Switzerland. He is a member of several Swiss and international societies in the field of nephrology and hypertension. He is a member of the Scientific Council of the European Society of Hypertension (ESH) and a committee member of the Swiss Society of Hypertension. Professor Burnier is President Elect of the Swiss Society of Nephrology, President of the ethical review board of the University of Lausanne and a Board Member of Swissmedic, the Swiss Agency for Therapeutic Products. He is on the Editorial Board of several journals, including Hypertension and Blood Pressure. Professor Burnier trained in internal medicine and nephrology in Lausanne and at the University of Colorado Health Science Centre.